Palau

Diabetes estimates (20-79 y)
People with diabetes, in 1,000s	-	1.4	2.7	2.5
Age-standardised prevalence of diabetes, %	-	11.1	19.3	21.2
Proportion of people with undiagnosed diabetes, %	-	-	56.3	-
People with undiagnosed diabetes, in 1,000s	-	-	1.5	-

Impaired Fasting Glucose (IFG)
People with IFG, in 1,000s	-	-	1.8	1.7
Age-standardised prevalence of IFG, %	-	-	14.0	14.3

Impaired Glucose Tolerance (IGT)
People with IGT, in 1,000s	-	1.1	1.1	1.0
Age-standardised prevalence of IGT, %	-	9.4	7.8	8.5

Mortality attributable to diabetes (20-79 y)
Deaths attributable to diabetes	-	17.0	21.9	-
Proportion of diabetes-related deaths in people 20-79 y, %	-	-	14.5	-

Hyperglycaemia in pregnancy (HIP) (20-49 y)
Live births affected by HIP	-	-	-	-
Prevalence of gestational diabetes mellitus (GDM), %	-	-	-	-
Live births affected by other types of diabetes first detected in pregnancy	-	-	-	-
Live births affected by other types of diabetes detected prior to pregnancy	-	-	-	-

Diabetes-related health expenditure
Total diabetes-related health expenditure, USD million	-	-	10.3	9.8
Total diabetes-related health expenditure, ID million	-	-	12.0	11.4
Diabetes-related health expenditure per person, USD	-	1,318.0	3,858.2	3,977.9
Diabetes-related health expenditure per person, ID	-	-	4,503.1	4,642.8

Type 1 diabetes estimates in children and adolescents
People with type 1 diabetes (all age groups)	-	-	-	-
People with type 1 diabetes (0-19 y)	-	-	-	-

Demographics
Total adult population (20-79 y), in 1,000s	-	12.3	12.8	11.7
Population of children and adolescents (0-19 y)	-	-	-	-